Bttx stock forecast.

Aug 10, 2023 · High Growth Earnings: BTTX is forecast to remain unprofitable over the next 3 years. Revenue vs Market : BTTX's revenue (68.3% per year) is forecast to grow faster than the US market (7.8% per year).

Bttx stock forecast. Things To Know About Bttx stock forecast.

TipRanks is a platform that provides comprehensive data and analysis on stocks, including Better Therapeutics, Inc. (BTTX), a digital therapeutics company. Find out the latest price targets, ratings, news, and earnings for BTTX on TipRanks.Nov 25, 2023 · After registering a 3.29% upside in the last session, Better Therapeutics Inc (BTTX) has traded red over the past five days. The stock hit a weekly high of 0.2280 this Friday, 11/24/23, jumping 3.29% in its intraday price action. The 5-day price performance for the stock is 20.07%, and 12.71% over 30 days. Find the latest eHealth, Inc. (EHTH) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...It follows that stock’s current price would drop -5194.12% in reaching the projected high whereas dropping to the targeted low would mean a loss of -782.35% for stock’s current value. Better Therapeutics Inc (BTTX) estimates and forecastsBetter Therapeutics (BTTX) Stock Forecast & Price Prediction. Estimation of the future price movement of Better Therapeutics stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Current. -$0.19. 1 Month Ago. -$0.26. 3 Months Ago. -$0.31. Better Therapeutics Inc. analyst estimates, including BTTX earnings per share estimates and analyst recommendations.Web

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Dec 1, 2023 · BTTX Earnings Date and Information. Better Therapeutics last posted its quarterly earnings results on November 9th, 2023. The reported ($0.15) earnings per share for the quarter. Better Therapeutics has generated ($1.15) earnings per share over the last year ( ($1.15) diluted earnings per share). Earnings for Better Therapeutics are expected to ... Better Therapeutics Stock Chart and Share Price Forecast, Short-Term "BTTX" Stock Prediction for Next Days and Weeks Walletinvestor.com Better Therapeutics Inc (BTTX) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024The Missfresh stock price fell by -1.08% on the last day (Monday, 13th Nov 2023) from $0.738 to $0.730. During the last trading day the stock fluctuated 11.43% from a day low at $0.700 to a day high of $0.780. The price has fallen in 6 of the last 10 days and is down by -8.75% for this period.Find the latest SEC Filings data for Better Therapeutics, Inc. Common Stock (BTTX) at Nasdaq.com.Pear Therapeutics (PEAR) and Spero Health have extended a partnership for the former to provide the latter prescription digital therapeutics for the treatment of substance use.

(NASDAQ: BTTX) of San Francisco said its AspyreRx, a prescription-only app, was greenlighted by the Food and Drug Administration for "cognitive behavioral therapy," or CBT, for adult patients ...

The average Nokia stock price prediction forecasts a potential upside of 61.29% from the current NOK share price of $3.48. What is NOK's forecast return on equity ...

The 2 analysts offering 1 year price forecasts for BTTX have a max estimate of — and a min estimate of —. Analyst rating Based on 2 analysts giving stock ratings to BTTX in the past 3 months.According to our price prediction algorithm,Better Therapeutics, Inc. (BTTX) price will be around $0.47 in the next 2 weeks.This means it will decrease by -34.48% from the last closing price. This prediction may vary from other …Find the latest BARK, Inc. (BARK) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...Dec 4, 2023 · The projected low price target is $1.50 while the price target rests at a high of $9.00. In that case, then, we find that the current price level is -4636.84% off the targeted high while a plunge would see the stock gain -689.47% from current levels. Better Therapeutics Inc (BTTX) estimates and forecasts Find the latest Financials data for Better Therapeutics, Inc. Common Stock (BTTX) at Nasdaq.com.Better Therapeutics Stock (NASDAQ:BTTX), Guidance and Forecast. Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make ...The average Coupang stock price prediction forecasts a potential upside of 35.38% from the current CPNG share price of $16.25. What is CPNG's forecast return on ...

Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Ginkgo Bioworks Holdings Inc have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 1.25. The ...NOK Stock 12 Months Forecast. $5.68. (59.55% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Nokia in the last 3 months. The average price target is $5.68 with a high forecast of $6.00 and a low forecast of $5.10. The average price target represents a 59.55% change from the last price of $3.56. Latest SEC filings for Better Therapeutics, Inc. (BTTX).According to our current BTTX stock forecast, the value of Better Therapeutics, Inc. shares will rise by 24.54% and reach $ 0.241978 per share by December 3, 2023. According to …WebEarnings Summary. For their last quarter, Better Therapeutics (BTTX) reported earnings of -$0.15 per share. This reflects a breakeven earnings surprise. Look out for BTTX's next earnings release ...Stock Price Forecast The 2 analysts offering 12-month price forecasts for Better Therapeutics Inc have a median target of 5.25, with a high estimate of 9.00 and a low estimate of 1.50.

View research reports from Argus and trade ideas from Trading Central to understand future stock performances and find high performing trade ideas.Stock Price Forecast According to 1 stock analyst, the 12-month stock price forecast for ACXP stock stock is $13, which predicts an increase of 243.01%. On average, analysts rate ACXP stock stock as a strong buy.

Welcome! Select a username of your choice. Username . 6 to 20 characters, no spaces or special charactersFind real-time ONPH - Oncology Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. Find real-time DNA - Ginkgo Bioworks Holdings Inc stock quotes, company profile, news and forecasts from CNN Business.Nov 17, 2023 · Based on short-term price targets offered by two analysts, the average price target for Better Therapeutics, Inc. comes to $6.00. The forecasts range from a low of $3.00 to a high of $9.00. The ... Mountain Crest Acquisition Corp II Stock Earnings. The value each BTTX share was expected to gain vs. the value that each BTTX share actually gained. BTTX ( BTTX) reported Q3 2023 earnings per share (EPS) of -$0.15, beating estimates of -$0.20 by 21.90%. In the same quarter last year, BTTX 's earnings per share (EPS) was -$0.48.Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buyDiscover historical prices for BTTX stock on Yahoo Finance. View daily, weekly or monthly format back to when Better Therapeutics, Inc. stock was issued. ... Better Therapeutics, Inc. (BTTX ...

Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buy

According to one analyst, the rating for SINT stock is "Strong Buy" and the 12-month stock price forecast is $6.0. Price Target. $6.0 (1,488.98% upside) Analyst Consensus: Strong Buy. Stock Forecasts. News. All; Videos; Press Press Releases; Conversation; ... Other symbols: ARQT BTTX EVLO HSCS.

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Nokia Corp - ADR share forecasts, stock quote and buy / sell signals below. According to present data Nokia Corp - ADR's NOK shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Based on short-term price targets offered by two analysts, the average price target for Better Therapeutics, Inc. comes to $6.00. The forecasts range from a low of $3.00 to a high of $9.00. The ...(NASDAQ: BTTX) of San Francisco said its AspyreRx, a prescription-only app, was greenlighted by the Food and Drug Administration for "cognitive behavioral therapy," or CBT, for adult patients ...Stock Price Forecast The 2 analysts offering 12-month price forecasts for Acurx Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 13.00 and a low estimate of 10.00.View today's Better Therapeutics Inc stock price and latest BTTX news and analysis. Create real-time notifications to follow any changes in the live stock price. Find the latest Sidus Space, Inc. (SIDU) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Better Therapeutics Inc (BTTX) $0.48 0.03 (5.00%) 16:00 EDT BTTX Stock Quote Delayed 30 Minutes.Best Stocks & ETFs. ... Better Therapeutics, Inc. BTTX shares gained 51.1% to $1.36 in pre-market trading after the FDA ... News Penny Stocks Small Cap Pre-Market Outlook Markets Movers Trading ...Get the latest BTTX stock quote, history, news and other vital information to help you with your stock trading and investing. See the current price, performance outlook, earnings date, dividend and more for BTTX, a biotechnology company developing treatments for neurological disorders.Find the latest Enovix Corporation (ENVX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...

View Better Therapeutics, Inc BTTX investment & stock information. Get the latest Better Therapeutics, Inc BTTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Hycroft Mining Holding Corporation - Class A Stock Forecast, HYMC stock price prediction. Price target in 14 days: 3.973 USD. The best long-term & short-term Hycroft ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.Instagram:https://instagram. gazelle com reviewsis trading legitwashington dental coverageinvest 100000 11 Jul 2023 ... Good Morning Traders! Watch The Starting Line for the best insights on the stock ... Dividend Journey Update (24): SCHD ETF Analysis. Dividend ...Better Therapeutics, Inc. (NASDAQ: BTTX ), a pioneer in developing prescription digital therapeutics (PDTs) to treat cardiometabolic diseases, today announced it has completed the enrollment of 1,000 participants across two studies as part of its ongoing clinical program to evaluate the long-term effectiveness of AspyreRx TM (formerly BT-001). copper etfs listthred up stock View research reports from Argus and trade ideas from Trading Central to understand future stock performances and find high performing trade ideas.The Better Therapeutics, Inc. stock price gained 5.06% on the last trading day (Friday, 24th Nov 2023), rising from $0.198 to $0.208. During the last trading day the stock fluctuated 21.93% from a day low at $0.187 to a day high of $0.228. The price has been going up and down for this period, and there has been a 35.53% gain for the last 2 weeks. jefferies financial Stock Price Forecast. The 3 analysts offering 12-month price forecasts for UpHealth Inc have a median target of 7.00, with a high estimate of 9.75 and a low estimate of 4.30. The median estimate ...Nov 20, 2023 · If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended BTTX as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Better Therapeutics Inc’s EPS for the current quarter is expected to be -$0.13.